Tech Software’s offerings will round out a growing portfolio of compliance and research solutions (Lake Success, NY) — BRANY announced today its acquisition of Tech…
Tech Software’s offerings will round out a growing portfolio of compliance and research solutions (Lake Success, NY) — BRANY announced today its acquisition of Tech…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
The Americans with Disabilities Act (ADA) celebrates its 32nd anniversary while continuing to affirm the inherent dignity of every person, regardless of disability. The HHS…
The National Institutes of Health (NIH) released a “Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes.” This notice highlights NIH’s…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The U.S. Food and Drug Administration (FDA) released new draft guidance entitled Conducting Remote Regulatory Assessments: Questions and Answers. Remote regulatory assessments (RRAs) are a tool…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
The U.S. Department of Education (ED) has proposed to amend the regulations guiding Title IX implementation. The proposed changes would enable schools of all sizes,…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
In response to the Supreme Court’s recent decision in Dobbs v. Jackson Women’s Health Organization, the HHS Office of Civil Rights has issued two guidance…
In June of 2022, the U.S. Food and Drug Administration (FDA) released new draft guidance for industry, FDA staff, and other stakeholders. When finalized, the…